link_id stringlengths 25 25 | evidence_group_id stringlengths 22 22 | pmid int64 1.8M 42.2M | nct_id stringlengths 11 11 | claim_type stringclasses 6
values | claim_direction stringclasses 6
values | claim_strength stringclasses 3
values | n_results int64 0 126 | outcome_types_present stringclasses 5
values | result_ids stringclasses 249
values | checkability stringclasses 2
values | verification stringclasses 1
value | evidence_span stringclasses 21
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLAIM_RESULT_ed933f99a331 | CLUST_42cf28b90f23786c | 28,555,075 | NCT00088699 | association_claim | associated | source_reported | 2 | PRIMARY | RESULT_35dc96b4efd4; RESULT_29d3fd110100 | checkable | not_assessed | associated with |
CLAIM_RESULT_ceefcfc56571 | CLUST_4e7a026f3ab4be13 | 17,074,942 | NCT01047124 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_84febce21067 | CLUST_ea98fb7f35313ac9 | 14,627,997 | NCT01075529 | superiority_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_61787c6167cc | CLUST_b91290969bb87306 | 27,771,973 | NCT01253421 | superiority_claim | improved | directionally_supported | 10 | PRIMARY; SECONDARY | RESULT_a514a0426b57; RESULT_109fc92367d9; RESULT_3f811f207ed6; RESULT_c64347a17841; RESULT_7aa6aa1fd46a; RESULT_e9665610dc6d; RESULT_1cfbd3641e56; RESULT_8047d23eff5b; RESULT_3aad1e04edbb; RESULT_e72c684572e6 | checkable | not_assessed | reduced |
CLAIM_RESULT_24e5626f152a | CLUST_4c9b788e97434084 | 29,962,359 | NCT01407094 | association_claim | associated | source_reported | 1 | PRIMARY | RESULT_8c2f20287adf | checkable | not_assessed | associated with |
CLAIM_RESULT_61718f10a282 | CLUST_4d610791b6abd7bc | 26,279,130 | NCT01421342 | efficacy_claim | unclear | source_reported | 4 | PRIMARY; SECONDARY | RESULT_f68f3a81ed8b; RESULT_582b9f5b9266; RESULT_6d4a83504873; RESULT_3cf0741ee7c8 | checkable | not_assessed | efficacy |
CLAIM_RESULT_39a565a97a04 | CLUST_6318117fa8d081c7 | 19,632,969 | NCT01663649 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_e7cd5c193b9d | CLUST_6318117fa8d081c7 | 19,632,969 | NCT01663649 | efficacy_claim | associated | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | effective in |
CLAIM_RESULT_cd6de1125664 | CLUST_9c76d8d2398ea3da | 30,583,852 | NCT02076425 | superiority_claim | improved | statistically_supported | 3 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_510d7a0679bd; RESULT_ff3353871dcd; RESULT_f5a2fb0b293d | checkable | not_assessed | reduced |
CLAIM_RESULT_5ec6c0db66d3 | CLUST_9c76d8d2398ea3da | 30,583,852 | NCT02076425 | association_claim | improved | directionally_supported | 3 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_510d7a0679bd; RESULT_ff3353871dcd; RESULT_f5a2fb0b293d | checkable | not_assessed | associated with |
CLAIM_RESULT_74b17cd35ae6 | CLUST_4e7a026f3ab4be13 | 17,074,942 | NCT02263872 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_ce7f8f217d8b | CLUST_4e7a026f3ab4be13 | 23,504,697 | NCT02263872 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_33d2e70eead5 | CLUST_4e7a026f3ab4be13 | 18,073,775 | NCT02263872 | superiority_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_7a5562dc1bde | CLUST_4ac918e56e5082e8 | 16,881,773 | NCT02278224 | efficacy_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_8407426a99de | CLUST_4ac918e56e5082e8 | 12,946,886 | NCT02358343 | association_claim | associated | source_reported | 15 | PRIMARY; SECONDARY | RESULT_1eeb1dde63a6; RESULT_4830f7d88ac9; RESULT_8c92a962292e; RESULT_3b934513dd2f; RESULT_79920e0c869a; RESULT_40f8711bb578; RESULT_2ab0e676d48b; RESULT_3ca9a27e8521; RESULT_d2a51dfa672b; RESULT_8c34b54cfc1a; RESULT_0aadbbda5b93; RESULT_9f9ce6da693e; RESULT_9abc8cb4c2db; RESULT_736f63c08481; RESULT_b74c1c247bad | checkable | not_assessed | correlated with |
CLAIM_RESULT_147f303d5fdf | CLUST_4ac918e56e5082e8 | 12,946,886 | NCT02361684 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | correlated with |
CLAIM_RESULT_96de3699a375 | CLUST_4ac918e56e5082e8 | 11,556,941 | NCT02361684 | superiority_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_40ced5d97526 | CLUST_4ac918e56e5082e8 | 20,444,251 | NCT02361684 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_7d7fb9731527 | CLUST_4ac918e56e5082e8 | 12,946,886 | NCT02389660 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | correlated with |
CLAIM_RESULT_17cba05967e9 | CLUST_4ac918e56e5082e8 | 11,556,941 | NCT02389660 | superiority_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_f24e9622009a | CLUST_f2c08b71de80bd2d | 31,332,902 | NCT02466958 | no_difference_claim | no_difference | source_reported | 3 | PRIMARY; SECONDARY | RESULT_0277f68f49bc; RESULT_aa124a49f0d1; RESULT_17b4dc0302ee | checkable | not_assessed | did not differ |
CLAIM_RESULT_43288988f3a0 | CLUST_f2c08b71de80bd2d | 31,332,902 | NCT02466958 | safety_claim | improved | directionally_supported | 3 | PRIMARY; SECONDARY | RESULT_0277f68f49bc; RESULT_aa124a49f0d1; RESULT_17b4dc0302ee | checkable | not_assessed | adverse events were |
CLAIM_RESULT_123157471d80 | CLUST_f2c08b71de80bd2d | 31,332,902 | NCT02466958 | association_claim | improved | directionally_supported | 3 | PRIMARY; SECONDARY | RESULT_0277f68f49bc; RESULT_aa124a49f0d1; RESULT_17b4dc0302ee | checkable | not_assessed | associated with |
CLAIM_RESULT_35457f318b26 | CLUST_f2c08b71de80bd2d | 31,332,902 | NCT02466958 | efficacy_claim | improved | directionally_supported | 3 | PRIMARY; SECONDARY | RESULT_0277f68f49bc; RESULT_aa124a49f0d1; RESULT_17b4dc0302ee | checkable | not_assessed | efficacy |
CLAIM_RESULT_d508edfda81c | CLUST_4e7a026f3ab4be13 | 18,073,775 | NCT02628054 | superiority_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_56ac8ec17300 | CLUST_4f14c9fa6982a770 | 29,107,036 | NCT02874131 | efficacy_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_ca2492234f24 | CLUST_4f14c9fa6982a770 | 37,418,778 | NCT02874131 | no_difference_claim | no_difference | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | no significant difference |
CLAIM_RESULT_4386b03d58cd | CLUST_57aacf0f91cc6939 | 26,343,603 | NCT03062150 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_1e7aa7380bdf | CLUST_6a3eb25431055973 | 20,439,832 | NCT03068715 | superiority_claim | no_difference | statistically_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | greater than |
CLAIM_RESULT_dd9869051e51 | CLUST_6a3eb25431055973 | 20,439,832 | NCT03068715 | no_difference_claim | no_difference | statistically_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | did not differ |
CLAIM_RESULT_4574da0086db | CLUST_6a3eb25431055973 | 20,439,832 | NCT03068715 | efficacy_claim | no_difference | statistically_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | efficacy |
CLAIM_RESULT_ccd602ae9886 | CLUST_6a3eb25431055973 | 8,547,583 | NCT03068715 | safety_claim | improved | statistically_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | well tolerated |
CLAIM_RESULT_3cd01b2ce9bf | CLUST_6a3eb25431055973 | 8,684,201 | NCT03068715 | association_claim | unclear | source_reported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | linked to |
CLAIM_RESULT_4688dacb94f9 | CLUST_6a3eb25431055973 | 26,850,210 | NCT03068715 | efficacy_claim | unclear | statistically_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | efficacy |
CLAIM_RESULT_6c30874c8872 | CLUST_6a3eb25431055973 | 25,281,475 | NCT03068715 | superiority_claim | improved | directionally_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | increased |
CLAIM_RESULT_4d401b235c50 | CLUST_6a3eb25431055973 | 25,450,537 | NCT03068715 | superiority_claim | improved | directionally_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | reduced |
CLAIM_RESULT_29c5866678f6 | CLUST_6a3eb25431055973 | 25,450,537 | NCT03068715 | efficacy_claim | improved | directionally_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | efficacy |
CLAIM_RESULT_b6f39930646f | CLUST_6a3eb25431055973 | 24,411,682 | NCT03068715 | superiority_claim | unclear | statistically_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | superior to |
CLAIM_RESULT_cc1fbed733df | CLUST_6a3eb25431055973 | 24,411,682 | NCT03068715 | efficacy_claim | unclear | statistically_supported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | efficacy |
CLAIM_RESULT_7cf67b10f77b | CLUST_6a3eb25431055973 | 25,430,687 | NCT03068715 | superiority_claim | unclear | source_reported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | increased |
CLAIM_RESULT_a2c2b4f8de00 | CLUST_6a3eb25431055973 | 25,430,687 | NCT03068715 | efficacy_claim | unclear | source_reported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | efficacy |
CLAIM_RESULT_406712e73321 | CLUST_6a3eb25431055973 | 19,862,614 | NCT03068715 | efficacy_claim | unclear | source_reported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | efficacy |
CLAIM_RESULT_d89430f23260 | CLUST_6a3eb25431055973 | 20,734,360 | NCT03068715 | superiority_claim | unclear | source_reported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | increased |
CLAIM_RESULT_146d99928b16 | CLUST_6a3eb25431055973 | 20,734,360 | NCT03068715 | safety_claim | unclear | source_reported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | safety profile |
CLAIM_RESULT_b75ee65b9522 | CLUST_6a3eb25431055973 | 20,734,360 | NCT03068715 | efficacy_claim | unclear | source_reported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | efficacy |
CLAIM_RESULT_70984287e326 | CLUST_6a3eb25431055973 | 8,524,021 | NCT03068715 | association_claim | associated | source_reported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | associated with |
CLAIM_RESULT_ea9ed39fbd6c | CLUST_6a3eb25431055973 | 12,506,194 | NCT03068715 | superiority_claim | unclear | source_reported | 9 | PRIMARY; SECONDARY | RESULT_41d5ed327a3b; RESULT_dd80d1f24f2a; RESULT_fa9530bcfc5a; RESULT_a7ecc880038f; RESULT_97d93e1dc362; RESULT_d158ecedec29; RESULT_84f3be5fe951; RESULT_90721710ca90; RESULT_bc5ece92e839 | checkable | not_assessed | increased |
CLAIM_RESULT_c80408ebe609 | CLUST_4ac918e56e5082e8 | 29,516,993 | NCT03170362 | superiority_claim | unclear | source_reported | 4 | PRIMARY; SECONDARY | RESULT_e62d22f02b18; RESULT_0213b2b7d067; RESULT_6cf8ac7a518d; RESULT_a608a51c7493 | checkable | not_assessed | increased |
CLAIM_RESULT_baa50e6c21fb | CLUST_50845b06030fd11d | 17,846,259 | NCT03191994 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_55876dc9c9e8 | CLUST_50845b06030fd11d | 10,547,175 | NCT03191994 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_3819d8bf55c8 | CLUST_50845b06030fd11d | 10,547,175 | NCT03191994 | no_difference_claim | no_difference | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | did not differ |
CLAIM_RESULT_093852b3700a | CLUST_50845b06030fd11d | 10,547,175 | NCT03191994 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_e7f9cfb92abb | CLUST_50845b06030fd11d | 10,547,175 | NCT03191994 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | effective in |
CLAIM_RESULT_bf0f97e92c0d | CLUST_50845b06030fd11d | 21,531,985 | NCT03191994 | association_claim | worsened | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_3d8a9ba1cf45 | CLUST_50845b06030fd11d | 21,531,985 | NCT03191994 | association_claim | worsened | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_3c60777ee1eb | CLUST_12c5c88de77a3580 | 29,119,217 | NCT03429075 | safety_claim | unclear | statistically_supported | 7 | PRIMARY; SECONDARY | RESULT_0056b5df167f; RESULT_ee48461daf63; RESULT_e9c01178b932; RESULT_ee51bec24579; RESULT_79ebf4fad261; RESULT_f750c242f78d; RESULT_8167616312f8 | checkable | not_assessed | well tolerated |
CLAIM_RESULT_7f052fae5dc3 | CLUST_12c5c88de77a3580 | 29,119,217 | NCT03429075 | efficacy_claim | unclear | statistically_supported | 7 | PRIMARY; SECONDARY | RESULT_0056b5df167f; RESULT_ee48461daf63; RESULT_e9c01178b932; RESULT_ee51bec24579; RESULT_79ebf4fad261; RESULT_f750c242f78d; RESULT_8167616312f8 | checkable | not_assessed | efficacy |
CLAIM_RESULT_b1d58fe0851a | CLUST_6318117fa8d081c7 | 16,585,467 | NCT03740009 | association_claim | worsened | source_reported | 2 | PRIMARY | RESULT_b479cde02d42; RESULT_ef621611996f | checkable | not_assessed | increased |
CLAIM_RESULT_492ff87afaa5 | CLUST_6318117fa8d081c7 | 16,585,467 | NCT03740009 | association_claim | worsened | directionally_supported | 2 | PRIMARY | RESULT_b479cde02d42; RESULT_ef621611996f | checkable | not_assessed | associated with |
CLAIM_RESULT_788a78c981ca | CLUST_6318117fa8d081c7 | 2,748,771 | NCT03740009 | superiority_claim | unclear | source_reported | 2 | PRIMARY | RESULT_b479cde02d42; RESULT_ef621611996f | checkable | not_assessed | greater than |
CLAIM_RESULT_64a4f368ef21 | CLUST_42cf28b90f23786c | 26,423,481 | NCT04414943 | superiority_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_1ea49f3c42fe | CLUST_42cf28b90f23786c | 26,423,481 | NCT04414943 | efficacy_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_1d745abc493b | CLUST_7dc2498e8daab3aa | 31,647,774 | NCT04619121 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_1b56dda70de0 | CLUST_7dc2498e8daab3aa | 31,647,774 | NCT04619121 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_4d6b6853bf39 | CLUST_e86c9e82d083f1cb | 28,768,493 | NCT04638231 | efficacy_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_3bebdb154d0a | CLUST_4ac918e56e5082e8 | 11,556,941 | NCT04777006 | superiority_claim | unclear | statistically_supported | 56 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_74b76d6fab80; RESULT_d2109e085929; RESULT_e60f0b90ef1d; RESULT_d2a8508ef7f6; RESULT_0fa41107595f; RESULT_6849a593c396; RESULT_193a48b6212d; RESULT_eb7f62eaa26d; RESULT_3f3ee2fcadd3; RESULT_a4f86367a4f5; RESULT_19b08025ede3; RESULT_2b469e058b8c; RESULT_84c688f61fc0; RESULT_427400b67c83; RESULT_dd438cb220b6; RESUL... | checkable | not_assessed | increased |
CLAIM_RESULT_f93701c90c92 | CLUST_6318117fa8d081c7 | 12,813,115 | NCT04975100 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_1795e50a1db8 | CLUST_3ab193df5bd3d7d1 | 29,689,693 | NCT05047952 | no_difference_claim | no_difference | statistically_supported | 3 | PRIMARY; SECONDARY | RESULT_ec2dbebfd6a3; RESULT_2e53963cbbd7; RESULT_a5268f4a9ef2 | checkable | not_assessed | did not differ |
CLAIM_RESULT_2ae640fcb034 | CLUST_3ab193df5bd3d7d1 | 29,689,693 | NCT05047952 | efficacy_claim | no_difference | statistically_supported | 3 | PRIMARY; SECONDARY | RESULT_ec2dbebfd6a3; RESULT_2e53963cbbd7; RESULT_a5268f4a9ef2 | checkable | not_assessed | efficacy |
CLAIM_RESULT_623c199e3f80 | CLUST_3ab193df5bd3d7d1 | 27,780,334 | NCT05047952 | efficacy_claim | improved | statistically_supported | 3 | PRIMARY; SECONDARY | RESULT_ec2dbebfd6a3; RESULT_2e53963cbbd7; RESULT_a5268f4a9ef2 | checkable | not_assessed | efficacy |
CLAIM_RESULT_d2613466e5dc | CLUST_3ab193df5bd3d7d1 | 31,404,802 | NCT05047952 | association_claim | associated | source_reported | 3 | PRIMARY; SECONDARY | RESULT_ec2dbebfd6a3; RESULT_2e53963cbbd7; RESULT_a5268f4a9ef2 | checkable | not_assessed | increased |
CLAIM_RESULT_35d623e09684 | CLUST_3ab193df5bd3d7d1 | 31,404,802 | NCT05047952 | association_claim | associated | source_reported | 3 | PRIMARY; SECONDARY | RESULT_ec2dbebfd6a3; RESULT_2e53963cbbd7; RESULT_a5268f4a9ef2 | checkable | not_assessed | associated with |
CLAIM_RESULT_2f709bfe8224 | CLUST_3ab193df5bd3d7d1 | 31,530,216 | NCT05047952 | association_claim | associated | source_reported | 3 | PRIMARY; SECONDARY | RESULT_ec2dbebfd6a3; RESULT_2e53963cbbd7; RESULT_a5268f4a9ef2 | checkable | not_assessed | associated with |
CLAIM_RESULT_33c48bc1dfbb | CLUST_c592da27c093cdef | 29,763,711 | NCT05436613 | superiority_claim | improved | statistically_supported | 4 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_5bf29f725abe; RESULT_54f23a3f4b99; RESULT_50f091016c81; RESULT_d87c3df1d173 | checkable | not_assessed | reduced |
CLAIM_RESULT_42e650c7896e | CLUST_c592da27c093cdef | 29,763,711 | NCT05436613 | no_difference_claim | no_difference | statistically_supported | 4 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_5bf29f725abe; RESULT_54f23a3f4b99; RESULT_50f091016c81; RESULT_d87c3df1d173 | checkable | not_assessed | no difference |
CLAIM_RESULT_5aeedda95955 | CLUST_c592da27c093cdef | 29,763,711 | NCT05436613 | efficacy_claim | improved | statistically_supported | 4 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_5bf29f725abe; RESULT_54f23a3f4b99; RESULT_50f091016c81; RESULT_d87c3df1d173 | checkable | not_assessed | efficacy |
CLAIM_RESULT_7896e9c89503 | CLUST_c592da27c093cdef | 30,917,990 | NCT05436613 | superiority_claim | associated | statistically_supported | 4 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_5bf29f725abe; RESULT_54f23a3f4b99; RESULT_50f091016c81; RESULT_d87c3df1d173 | checkable | not_assessed | increased |
CLAIM_RESULT_552bffca8c14 | CLUST_c592da27c093cdef | 30,917,990 | NCT05436613 | association_claim | associated | source_reported | 4 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_5bf29f725abe; RESULT_54f23a3f4b99; RESULT_50f091016c81; RESULT_d87c3df1d173 | checkable | not_assessed | associated with |
CLAIM_RESULT_3e3b198fe281 | CLUST_c592da27c093cdef | 30,917,990 | NCT05436613 | efficacy_claim | associated | statistically_supported | 4 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_5bf29f725abe; RESULT_54f23a3f4b99; RESULT_50f091016c81; RESULT_d87c3df1d173 | checkable | not_assessed | efficacy |
CLAIM_RESULT_f6b2fff198f3 | CLUST_c592da27c093cdef | 33,706,656 | NCT05436613 | efficacy_claim | unclear | source_reported | 4 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_5bf29f725abe; RESULT_54f23a3f4b99; RESULT_50f091016c81; RESULT_d87c3df1d173 | checkable | not_assessed | efficacy |
CLAIM_RESULT_2a293364c20c | CLUST_c592da27c093cdef | 35,839,661 | NCT05436613 | association_claim | associated | source_reported | 4 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_5bf29f725abe; RESULT_54f23a3f4b99; RESULT_50f091016c81; RESULT_d87c3df1d173 | checkable | not_assessed | associated with |
CLAIM_RESULT_d2f1c4a41d24 | CLUST_c592da27c093cdef | 35,839,661 | NCT05436613 | association_claim | associated | source_reported | 4 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_5bf29f725abe; RESULT_54f23a3f4b99; RESULT_50f091016c81; RESULT_d87c3df1d173 | checkable | not_assessed | efficacy |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.